148 related articles for article (PubMed ID: 31082389)
1. Time to reconsider extended erythropoietin treatment for infantile traumatic brain injury?
Jantzie L; El Demerdash N; Newville JC; Robinson S
Exp Neurol; 2019 Aug; 318():205-215. PubMed ID: 31082389
[TBL] [Abstract][Full Text] [Related]
2. Imaging and serum biomarkers reflecting the functional efficacy of extended erythropoietin treatment in rats following infantile traumatic brain injury.
Robinson S; Winer JL; Berkner J; Chan LA; Denson JL; Maxwell JR; Yang Y; Sillerud LO; Tasker RC; Meehan WP; Mannix R; Jantzie LL
J Neurosurg Pediatr; 2016 Jun; 17(6):739-55. PubMed ID: 26894518
[TBL] [Abstract][Full Text] [Related]
3. Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats.
Robinson S; Winer JL; Chan LAS; Oppong AY; Yellowhair TR; Maxwell JR; Andrews N; Yang Y; Sillerud LO; Meehan WP; Mannix R; Brigman JL; Jantzie LL
Front Neurol; 2018; 9():451. PubMed ID: 29971038
[TBL] [Abstract][Full Text] [Related]
4. Erythropoietin Treatment in Traumatic Brain Injury: Operation Brain Trauma Therapy.
Bramlett HM; Dietrich WD; Dixon CE; Shear DA; Schmid KE; Mondello S; Wang KK; Hayes RL; Povlishock JT; Tortella FC; Kochanek PM
J Neurotrauma; 2016 Mar; 33(6):538-52. PubMed ID: 26670694
[TBL] [Abstract][Full Text] [Related]
5. Erythropoietin in patients with traumatic brain injury and extracranial injury-A post hoc analysis of the erythropoietin traumatic brain injury trial.
Skrifvars MB; Bailey M; French C; Presneill J; Nichol A; Little L; Duranteau J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R;
J Trauma Acute Care Surg; 2017 Sep; 83(3):449-456. PubMed ID: 28590358
[TBL] [Abstract][Full Text] [Related]
6. Beneficial Effect of Erythropoietin Short Peptide on Acute Traumatic Brain Injury.
Wang B; Kang M; Marchese M; Rodriguez E; Lu W; Li X; Maeda Y; Dowling P
Neurotherapeutics; 2016 Apr; 13(2):418-27. PubMed ID: 26715414
[TBL] [Abstract][Full Text] [Related]
7. Cost-Effectiveness of Erythropoietin in Traumatic Brain Injury: A Multinational Trial-Based Economic Analysis.
Knott RJ; Harris A; Higgins A; Nichol A; French C; Little L; Haddad S; Presneill J; Arabi Y; Bailey M; Cooper DJ; Duranteau J; Huet O; Mak A; McArthur C; Pettilä V; Skrifvars MB; Vallance S; Varma D; Wills J; Bellomo R
J Neurotrauma; 2019 Sep; 36(17):2541-2548. PubMed ID: 30907230
[TBL] [Abstract][Full Text] [Related]
8. Therapeutic effect of erythropoietin in patients with traumatic brain injury: a meta-analysis of randomized controlled trials.
Liu WC; Wen L; Xie T; Wang H; Gong JB; Yang XF
J Neurosurg; 2017 Jul; 127(1):8-15. PubMed ID: 27367243
[TBL] [Abstract][Full Text] [Related]
9. The efficacy of erythropoietin in treating experimental traumatic brain injury: a systematic review of controlled trials in animal models.
Peng W; Xing Z; Yang J; Wang Y; Wang W; Huang W
J Neurosurg; 2014 Sep; 121(3):653-64. PubMed ID: 25036201
[TBL] [Abstract][Full Text] [Related]
10. Erythropoietin regulates immune/inflammatory reaction and improves neurological function outcomes in traumatic brain injury.
Zhou ZW; Li F; Zheng ZT; Li YD; Chen TH; Gao WW; Chen JL; Zhang JN
Brain Behav; 2017 Nov; 7(11):e00827. PubMed ID: 29201540
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin improved cognitive function and decreased hippocampal caspase activity in rat pups after traumatic brain injury.
Schober ME; Requena DF; Block B; Davis LJ; Rodesch C; Casper TC; Juul SE; Kesner RP; Lane RH
J Neurotrauma; 2014 Feb; 31(4):358-69. PubMed ID: 23972011
[TBL] [Abstract][Full Text] [Related]
12. The effect of recombinant erythropoietin on long-term outcome after moderate-to-severe traumatic brain injury.
Skrifvars MB; Luethi N; Bailey M; French C; Nichol A; Trapani T; McArthur C; Arabi YM; Bendel S; Cooper DJ; Bellomo R;
Intensive Care Med; 2023 Jul; 49(7):831-839. PubMed ID: 37405413
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of erythropoietin for traumatic brain injury.
Liu M; Wang AJ; Chen Y; Zhao G; Jiang Z; Wang X; Shi D; Zhang T; Sun B; He H; Williams Z; Hu K
BMC Neurol; 2020 Nov; 20(1):399. PubMed ID: 33138778
[TBL] [Abstract][Full Text] [Related]
14. [Erythropoietin and neuroprotection].
Chatagner A; Hüppi PS; Ha-Vinh Leuchter R; Sizonenko S
Arch Pediatr; 2010 Sep; 17 Suppl 3():S78-84. PubMed ID: 20728813
[TBL] [Abstract][Full Text] [Related]
15. Statistical analysis plan for the Erythropoietin in Traumatic Brain Injury trial: a randomised controlled trial of erythropoietin versus placebo in moderate and severe traumatic brain injury.
Presneill J; Little L; Nichol A; French C; Cooper DJ; Haddad S; Duranteau J; Huet O; Skrifvars M; Arabi Y; Bellomo R; ;
Trials; 2014 Dec; 15():501. PubMed ID: 25528574
[TBL] [Abstract][Full Text] [Related]
16. Therapeutic strategy of erythropoietin in neurological disorders.
Liu XB; Wang JA; Yu SP; Keogh CL; Wei L
CNS Neurol Disord Drug Targets; 2008 Jun; 7(3):227-34. PubMed ID: 18673207
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin for neonatal brain injury: opportunity and challenge.
Xiong T; Qu Y; Mu D; Ferriero D
Int J Dev Neurosci; 2011 Oct; 29(6):583-91. PubMed ID: 21277366
[TBL] [Abstract][Full Text] [Related]
18. Brain repair by hematopoietic growth factors in the subacute phase of traumatic brain injury.
Toshkezi G; Kyle M; Longo SL; Chin LS; Zhao LR
J Neurosurg; 2018 Nov; 129(5):1286-1294. PubMed ID: 29372883
[TBL] [Abstract][Full Text] [Related]
19. Effect of Erythropoietin and Stem Cells on Traumatic Brain Injury.
Tunc Ata M; Turgut G; Akbulut M; Kocyigit A; Karabulut A; Senol H; Turgut S
World Neurosurg; 2016 May; 89():355-61. PubMed ID: 26850972
[TBL] [Abstract][Full Text] [Related]
20. Cause and Timing of Death and Subgroup Differential Effects of Erythropoietin in the EPO-TBI Study.
Skrifvars MB; French C; Bailey M; Presneill J; Nichol A; Little L; Durantea J; Huet O; Haddad S; Arabi Y; McArthur C; Cooper DJ; Bellomo R
J Neurotrauma; 2018 Jan; 35(2):333-340. PubMed ID: 29020866
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
